Fulgent Genetics Net Change in Property, Plant, and Equipment 2015-2025 | FLGT

Fulgent Genetics net change in property, plant, and equipment from 2015 to 2025. Net change in property, plant, and equipment can be defined as the overall change in capital expenditures and sales of plant, property and equipment. This field is used if a company does not report separately sales and purchases of plant, property and equipment or is calculated as the sum of purchases and sales of PP&E
Fulgent Genetics Annual Net Change in Property, Plant, and Equipment
(Millions of US $)
2024 $-40
2023 $-21
2022 $-18
2021 $-24
2020 $-35
2019 $-1
2018 $-3
2017 $-5
2016 $-4
2015 $-2
2014 $-1
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.646B $0.283B
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.174B 54.11
Hims & Hers Health (HIMS) United States $13.701B 142.35
Tempus AI (TEM) United States $10.751B 0.00
IRhythm Technologies (IRTC) United States $4.508B 0.00
Inspire Medical Systems (INSP) United States $4.426B 69.15
Privia Health (PRVA) United States $2.989B 204.33
Enovis (ENOV) United States $1.969B 10.98
Clover Health Investments (CLOV) United States $1.878B 0.00
Schrodinger (SDGR) United States $1.573B 0.00
Phreesia (PHR) United States $1.516B 0.00
Omnicell (OMCL) United States $1.348B 23.78
Azenta (AZTA) United States $1.294B 60.15
10x Genomics (TXG) United States $1.118B 0.00
Butterfly Network (BFLY) United States $0.566B 0.00
Talkspace (TALK) United States $0.502B 150.00
Veradigm (MDRX) United States $0.476B 0.00
Claritev (CTEV) United States $0.472B 0.00
Standard BioTools (LAB) United States $0.399B 0.00
TruBridge (TBRG) United States $0.374B 830.67
Health Catalyst (HCAT) United States $0.274B 0.00
Nyxoah SA (NYXH) Belgium $0.262B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.192B 0.00
EUDA Health Holdings (EUDA) Singapore $0.144B 0.00
Pulmonx (LUNG) United States $0.135B 0.00
American Well (AMWL) United States $0.118B 0.00
MDxHealth SA (MDXH) Belgium $0.102B 0.00
CareCloud (CCLD) United States $0.090B 3.42
Outset Medical (OM) United States $0.070B 0.00
111 (YI) China $0.069B 0.00
Retrieve Medical Holdings (RMHI) United States $0.059B 0.00
P3 Health Partners (PIII) United States $0.058B 0.00
HeartBeam (BEAT) United States $0.056B 0.00
Zepp Health (ZEPP) Netherlands $0.039B 0.00
Zhongchao (ZCMD) China $0.031B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.014B 0.00
MSP Recovery (MSPR) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.005B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00